anti human vegf a Search Results


N/A
Rabbit Anti Human VEGFA Polyclonal Antigen affinity Purified (PBS with 0.05% NaN3 and 40% Glycerol, pH7.4) (Western Blot,IHC,ELISA) from Innovative Research is a polyclonal antibody in a liquid format, buffered in PBS with 0.05% NaN3
  Buy from Supplier

92
Cusabio anti vegf
Anti Vegf, supplied by Cusabio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+vegf+a/Rabbit+anti-Human+VEGFA+Polyclonal+Antibody/pmc08595284-55-53-55
Average 92 stars, based on 1 article reviews
anti vegf - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier

90
Becton Dickinson primary antibodies against human vegf
Primary Antibodies Against Human Vegf, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+vegf+a/anti+human+vegf+a/pm25944623-62-16-18
Average 90 stars, based on 1 article reviews
primary antibodies against human vegf - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Genentech inc pro-169 is a recombinant, humanized anti-vegf-a mab
ERG analysis of NZW rabbits as a function of time after intravitreal injections. a The effects of the intravitreal <t>PRO-169</t> (white bars) and ranibizumab (dark bars) on the dark-adapted ERG responses after 30 days of each injection. The dark-adapted retinal response is represented by the mean ± SEM V Max ratio of the ERG (b-wave). b Time dependent effects of repeated injections of PRO-169 and ranibizumab on retinal function of rabbits. The difference of the log semi saturation constant (experimental-control) is represented by the mean ± SEM. V Max ratios are around 1 and log σ differences are around 0, indicating no damage to the road system
Pro 169 Is A Recombinant, Humanized Anti Vegf A Mab, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+vegf+a/pro+169+is+a+recombinant++humanized+anti+vegf+a+mab/pmc07389522-36-0-24
Average 90 stars, based on 1 article reviews
pro-169 is a recombinant, humanized anti-vegf-a mab - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Autogen-Bioclear ltd 1 lg/ml rabbit anti-human vegfa
ERG analysis of NZW rabbits as a function of time after intravitreal injections. a The effects of the intravitreal <t>PRO-169</t> (white bars) and ranibizumab (dark bars) on the dark-adapted ERG responses after 30 days of each injection. The dark-adapted retinal response is represented by the mean ± SEM V Max ratio of the ERG (b-wave). b Time dependent effects of repeated injections of PRO-169 and ranibizumab on retinal function of rabbits. The difference of the log semi saturation constant (experimental-control) is represented by the mean ± SEM. V Max ratios are around 1 and log σ differences are around 0, indicating no damage to the road system
1 Lg/Ml Rabbit Anti Human Vegfa, supplied by Autogen-Bioclear ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+vegf+a/1+lg+ml+rabbit+anti+human+vegfa/pm17360962-113-42-45
Average 90 stars, based on 1 article reviews
1 lg/ml rabbit anti-human vegfa - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

93
Bio-Techne corporation human vegf165 antibody
ERG analysis of NZW rabbits as a function of time after intravitreal injections. a The effects of the intravitreal <t>PRO-169</t> (white bars) and ranibizumab (dark bars) on the dark-adapted ERG responses after 30 days of each injection. The dark-adapted retinal response is represented by the mean ± SEM V Max ratio of the ERG (b-wave). b Time dependent effects of repeated injections of PRO-169 and ranibizumab on retinal function of rabbits. The difference of the log semi saturation constant (experimental-control) is represented by the mean ± SEM. V Max ratios are around 1 and log σ differences are around 0, indicating no damage to the road system
Human Vegf165 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+vegf+a/Human+VEGF165+Antibody/bio-techne+corporation___ab-293-na
Average 93 stars, based on 1 article reviews
human vegf165 antibody - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

N/A
Goat Anti-Human VEGF / VEGF-A [+Biotin]
  Buy from Supplier

N/A
Rabbit anti-Human VEGFA Polyclonal Antibody
  Buy from Supplier

N/A
Goat Anti-Human VEGF / VEGF-A
  Buy from Supplier

N/A
Recombinant Mouse Antibody Fab Fragment is specific to Human VEGFA, expressed in Chinese Hamster Ovary cells(CHO).Products can be used for: Immunoprecipitation; Functional StudyStore at -20°C. Avoid multiple freeze/thaw cycles.http://www.creativebiolabs.net/Rcombinant-Anti-Human-VEGFA-Antibody-Fab-Fragment-4060.htm
  Buy from Supplier

N/A
Rabbit Anti Human VEGFA Monoclonal Clone ADB-22 from Innovative Research is a monoclonal antibody in a Liquid format, buffered in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol, 0.4-0.5mg/ml BSA.
  Buy from Supplier

Image Search Results


ERG analysis of NZW rabbits as a function of time after intravitreal injections. a The effects of the intravitreal PRO-169 (white bars) and ranibizumab (dark bars) on the dark-adapted ERG responses after 30 days of each injection. The dark-adapted retinal response is represented by the mean ± SEM V Max ratio of the ERG (b-wave). b Time dependent effects of repeated injections of PRO-169 and ranibizumab on retinal function of rabbits. The difference of the log semi saturation constant (experimental-control) is represented by the mean ± SEM. V Max ratios are around 1 and log σ differences are around 0, indicating no damage to the road system

Journal: International Journal of Retina and Vitreous

Article Title: Safety and tolerability evaluation after repeated intravitreal injections of a humanized anti-VEGF-A monoclonal antibody (PRO-169) versus ranibizumab in New Zealand white rabbits

doi: 10.1186/s40942-020-00235-y

Figure Lengend Snippet: ERG analysis of NZW rabbits as a function of time after intravitreal injections. a The effects of the intravitreal PRO-169 (white bars) and ranibizumab (dark bars) on the dark-adapted ERG responses after 30 days of each injection. The dark-adapted retinal response is represented by the mean ± SEM V Max ratio of the ERG (b-wave). b Time dependent effects of repeated injections of PRO-169 and ranibizumab on retinal function of rabbits. The difference of the log semi saturation constant (experimental-control) is represented by the mean ± SEM. V Max ratios are around 1 and log σ differences are around 0, indicating no damage to the road system

Article Snippet: PRO-169 is a recombinant, humanized anti-VEGF-A mAb with a molecular mass of 149 kDa, structurally similar and with a target specificity like bevacizumab (Avastin, Genentech, South San Francisco, CA) [ , ].

Techniques: Injection

Histologic examination of the central retina for PRO-169 ( a ) vs ranibizumab ( b ) after the 1st Ivt injection (D32), for PRO-169 ( c ) vs ranibizumab ( d ) after the 2nd Ivt injection (D63), and for PRO-169 ( e ) vs ranibizumab ( f ) after the 3rd Ivt injection (D94). No retinal toxicity was found in any eyes (x40)

Journal: International Journal of Retina and Vitreous

Article Title: Safety and tolerability evaluation after repeated intravitreal injections of a humanized anti-VEGF-A monoclonal antibody (PRO-169) versus ranibizumab in New Zealand white rabbits

doi: 10.1186/s40942-020-00235-y

Figure Lengend Snippet: Histologic examination of the central retina for PRO-169 ( a ) vs ranibizumab ( b ) after the 1st Ivt injection (D32), for PRO-169 ( c ) vs ranibizumab ( d ) after the 2nd Ivt injection (D63), and for PRO-169 ( e ) vs ranibizumab ( f ) after the 3rd Ivt injection (D94). No retinal toxicity was found in any eyes (x40)

Article Snippet: PRO-169 is a recombinant, humanized anti-VEGF-A mAb with a molecular mass of 149 kDa, structurally similar and with a target specificity like bevacizumab (Avastin, Genentech, South San Francisco, CA) [ , ].

Techniques: Injection